SKYDANCE VASCULAR ANNOUNCES FDA CLEARANCE FOR THE OSPREY V2-20
![](https://www.skydancevascular.com/wp-content/uploads/2023/04/Picture1.png)
Another step in improving PIVC patient safety and outcomes from SkyDance Vascular Delray Beach, Florida – [September 5, 2023] – SkyDance Vascular, Inc. (SkyDance), a pioneer in innovative medical technologies, proudly introduces its latest breakthrough product, the OspreyV2-20. Following the successful FDA clearance of the OspreyF20, the OspreyV2-20 represents a significant advancement in vascular access […]
SKYDANCE VASCULAR ANNOUNCES U.S. FDA CLEARANCE AND THE ISSUANCE OF NEW PATENTS FOR THE OSPREYIV CATHETER DELIVERY SYSTEM
![](https://www.skydancevascular.com/wp-content/uploads/2023/04/Picture1.png)
The latest technology from SkyDance Vascular is designed to improve safety measures for the use of Peripheral Intravenous Catheters (PIVC) DELRAY BEACH, Florida. (April 18, 2023) – Today, SkyDance Vascular, Inc. (SkyDance) announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the Osprey Peripheral IV Catheter System (OspreyIV), a revolution in peripheral vascular […]
SKYDANCE VASCULAR PUBLISHES PAPER IN JAVA ON GROUNDBREAKING PERIPHERAL INTRAVENOUS CATHETER (PIVC) DESIGN
![](https://www.skydancevascular.com/wp-content/uploads/2023/04/ava.png)
Skydance Vascular Study Shows a Reduction in Insertion-Related Contamination in an Ovine Study. The ovine study found that the Osprey PIVC, had superior outcomes compared to a traditional PIVC.”— JAVA DELRAY BEACH, FLORIDA, UNITED STATES, March 21, 2023 /EINPresswire.com/ — Skydance Vascular, a medical device company that re-imaged the Peripheral Intravenous Catheter (PIVC), has released […]
Skydance Vascular Successfully Closes Initial Seed Round
![](https://www.skydancevascular.com/wp-content/uploads/2022/05/AdobeStock_257333506-min-1024x341.jpeg)
Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market closes seed financing round of $2.5M. DELRAY BEACH, Florida (October 27, 2020) – SkyDance Vascular (SkyDance) today announced the completion of their initial seed funding round, securing $2.5M through private investments. The startup, founded in 2017, has reimagined the Peripheral Intravenous Catheter (PIV) designed to reduce the […]
Skydance Vascular Secures $3.3 Million In Additional Seed Funding
![](https://www.skydancevascular.com/wp-content/uploads/2022/05/needle-stick-injury-1024x682.jpg)
Innovative startup will further accelerate the safety of Peripheral Intravenous Catheters DELRAY BEACH, Florida (December 14, 2021) – SkyDance Vascular (“SkyDance” or “the Company”), a newly formed medical device company dedicated to reimagining the Peripheral Intravenous Catheter (PIV), today announced that it has closed $3.3 million in additional seed funding from a combination of existing and […]
Skydance Vascular Announces Issuance Of New U.s. Patent
![](https://www.skydancevascular.com/wp-content/uploads/2022/05/727337434.webp)
New patent provides additional safety measures for the use of Peripheral Intravenous Catheters (PIV) DELRAY BEACH, Florida (November 16, 2021) – SkyDance Vascular (“SkyDance” or “the Company”), a newly formed medical device company dedicated to reimagining the Peripheral Intravenous Catheter (PIV), today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice […]
Skydance Vascular Successfully Closes Initial Seed Round
![](https://www.skydancevascular.com/wp-content/uploads/2022/05/AdobeStock_257333506-min-1024x341.jpeg)
Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market closes seed financing round of $2.5M. DELRAY BEACH, Florida (October 27, 2020) – SkyDance Vascular (SkyDance) today announced the completion of their initial seed funding round, securing $2.5M through private investments. The startup, founded in 2017, has reimagined the Peripheral Intravenous Catheter (PIV) designed to reduce the […]
Skydance Vascular Launches New Website In Support Of Fund Raising Efforts
![](https://www.skydancevascular.com/wp-content/uploads/2022/05/AdobeStock_295359774-1024x576.jpeg)
Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market lays out current challenges and groundbreaking solution to a critical healthcare procedure. SkyDance Vascular (SkyDance), a company established to transform the market for Peripheral Intravenous Catheters (PIV), today announces the debut of a new website, www.skydancevascular.com, aimed at supporting its upcoming fund raising efforts. The new site comprehensively identifies […]
Skydance Vascular And Thasis Partner For Fund-raising Initiatives And Launch Strategy
![](https://www.skydancevascular.com/wp-content/uploads/2022/05/AdobeStock_42626503-min-1024x683.jpeg)
Innovative startup to introduce a newly designed catheter looking to reduce infection rates and complications from usage. SkyDance Vascular (SkyDance), a company aiming to transform the market for Peripheral Intravenous Catheters (PIV), has engaged Thasis LLC (Thasis) to assist with its fund-raising strategy and develop the appropriate marketing communications, platforms, and materials to clearly represent […]